Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
| Id | http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66872
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66872
|
|---|---|
| Preferred Name | Atazanavir |
| Definitions |
An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors.
|
| Synonyms |
ATAZANAVIR
Atazanavir
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Atazanavir
|
|---|---|
| Legacy Concept Name |
Atazanavir_Base
|
| CHEBI_ID |
CHEBI:37924
|
| Preferred_Name |
Atazanavir
|
| Semantic_Type |
Pharmacologic Substance
|
| prefixIRI |
Thesaurus:C66872
|
| DEFINITION |
An aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors.
|
| UMLS_CUI |
C1145759
|
| code |
C66872
|
| Chemical_Formula |
C38H52N6O7
|
| subClassOf | |
| type | |
| CAS_Registry |
198904-31-3
|
| FULL_SYN |
ATAZANAVIR
Atazanavir
|
| FDA_UNII_Code |
QZU4H47A3S
|
| Contributing_Source |
FDA
|
| Concept_In_Subset | |
| Has_Salt_Form |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |